Cargando…
非小细胞肺癌EGFR突变非侵入性检测技术研究进展
Over the past decade, the management model of cancer patients has gradually shifted to individual mode based on molecular mutation detection. Epidermal growth factor receptor (EGFR) gene mutation is an important driving factor in non-small cell lung cancer (NSCLC). Compared with traditional chemothe...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6318567/ https://www.ncbi.nlm.nih.gov/pubmed/30591099 http://dx.doi.org/10.3779/j.issn.1009-3419.2018.12.09 |